We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · October 12, 2020

ACE2 Levels in Relation to Risk Factors for COVID-19 in Patients With Arial Fibrillation

European Heart Journal

 

Additional Info

European Heart Journal
Angiotensin-Converting Enzyme 2 (ACE2) Levels in Relation to Risk Factors for COVID-19 in Two Large Cohorts of Patients With Atrial Fibrillation
Eur Heart J 2020 Sep 27;[EPub Ahead of Print], L Wallentin, J Lindbäck, N Eriksson, Z Hijazi, JW Eikelboom, MD Ezekowitz, CB Granger, RD Lopes, S Yusuf, J Oldgren, A Siegbahn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading